SCHEMBL564730

SCHEMBL564730

CCc1ccc(CC(C)=O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
POLB P06746 1/20 0.53
PLK1 P53350 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 1/20 0.44
LPL P06858 1/20 0.44
LIPG Q9Y5X9 1/20 0.44
SRC P12931 1/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
EGFR P00533 1/20 0.42
TP53 P04637 1/20 0.42
CA2 P00918 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
RAB9A P51151 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8403545 0.89 POLB (0.61) ALDH1A1POLBLMNAHPGDHSD17B10
Formamide SCHEMBL11082806 0.89 POLB (0.46) ALDH1A1POLBPLK1SMN1; SMN2LMNA
SCHEMBL7147959 0.82 ALDH1A1 (0.56) ALDH1A1PLK1SMN1; SMN2LMNALPL
SCHEMBL10775630 0.82 POLB (0.55) ALDH1A1POLBHPGDHSD17B10CA2
Acetic Acid SCHEMBL30839310 0.81 ALDH1A1 (0.68) ALDH1A1PLK1SMN1; SMN2LPLLIPG
SCHEMBL27781064 0.81 ALDH1A1 (0.50) ALDH1A1PLK1SMN1; SMN2LMNALPL
SCHEMBL13970533 0.81 ALDH1A1 (0.53) ALDH1A1POLBPLK1LPLLIPG
SCHEMBL4455 0.80 CA2 (0.62) ALDH1A1POLBLMNACA2RAB9A
SCHEMBL5536012 0.80 POLB (0.53) ALDH1A1POLBLMNAHPGDHSD17B10
SCHEMBL156207 0.80 ALDH1A1 (0.63) ALDH1A1POLBPLK1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250033082-A1 METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS ADAMA MAKHTESHIM LTD. (IL) 2025-01-30 US claimed
EP-4423178-A1 METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS ADAMA MAKHTESHIM LTD. (IL) 2024-09-04 EP claimed
CN-117250289-A Method for detecting content of p-methyl propiophenone in sample 湖南新领航检测技术有限公司 2023-12-19 CN claimed
WO-2023073536-A1 METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS ADAMA MAKHTESHIM LTD. (IL) 2023-05-04 WO claimed
CN-108997957-A A kind of white EVA packaging adhesive film and preparation method thereof 江苏鹿山光电科技有限公司 2018-12-14 CN claimed
CN-105542702-B A kind of ultraviolet curing urethane adhesive and preparation method thereof 华南理工大学 2018-11-13 CN claimed
CN-105542702-A Ultraviolet-cured polyurethane adhesive and preparation method thereof UNIV SOUTH CHINA TECH 2016-05-04 CN claimed
US-20250033082-A1 METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS ADAMA MAKHTESHIM LTD. (IL) 2025-01-30 US disclosed
CN-119330913-A Preparation method of eperisone hydrochloride 康普药业股份有限公司 2025-01-21 CN disclosed
US-20240368001-A1 SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2024-11-07 US disclosed
EP-4423178-A1 METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS ADAMA MAKHTESHIM LTD. (IL) 2024-09-04 EP disclosed
US-11987506-B2 Salt recovery solution and processes of use thereof AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2024-05-21 US disclosed
US-20230364255-A1 TRANSGLUTAMINASE-MEDIATED CONJUGATION HORIZON TECHNOLOGY FINANCE CORPORATION 2023-11-16 US disclosed
EP-1399430-A1 OXAZOL/ THIAZOL-DERIVATIVES ACTIVATORS OF THE HPPAR-ALPHA RECEPTOR GLAXO GROUP LIMITED (GB) 2004-03-24 EP disclosed
WO-2003053957-A1 BENZHYDRYL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (US) 2003-07-03 WO disclosed
WO-2002096895-A1 OXAZOL/ THIAZOL-DERIVATIVES ACTIVATORS OF THE HPPAR-ALPHA RECEPTOR GLAXO GROUP LIMITED (GB) 2002-12-05 WO disclosed
US-4638094-A OXIDATION OF PROPYLENEBENZENES UBE INDUSTRIES, LTD. (JP) 1987-01-20 US disclosed
US-4588749-A ANTIOBESITY AND HYPOGLYCEMIC AGENTS BEECHAM GROUP P.L.C. (GB) 1986-05-13 US disclosed
EP-0040000-B1 ARYLETHANOLAMINE DERIVATIVES, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS BEECHAM GROUP PLC (GB) 1983-10-12 EP disclosed
EP-0040000-A1 Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions BEECHAM GROUP PLC (GB) 1981-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230364255-A1 TRANSGLUTAMINASE-MEDIATED CONJUGATION TGM2, TGM1, TGM6 ALDH1A1 2525/4885POLB 895/4885PLK1 1200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.